Middle East and Africa Blood Coagulants Market Information, by Drug Class (Coagulation Factor (Plasma-derived Factors (Factor VIII and IX, Von Willebrand Disease Factor, Prothrombin Complex and others) and Recombinant Coagulation Factors (Factor VIII and IX, Von Willebrand Disease Factor, Prothrombin Complex and others)), Vitamin K analogues, Fibrinogen Analogues and others), by Clinical Indications (Accidents, Surgery, Hemophilia and Others) – Forecast till 2022
Blood coagulants are natural and synthetic substances which are useful in blocking the bleeding caused due to surgery, accidents, wounds, and disorders such as hemophilia. These drugs are included in the list of essential medicines of World Health Organization (WHO) and many countries. The market for blood coagulants is rising at a good rate due to several factors such as rise in accidents and surgeries, growth of geriatric population, growth of screening for hemophilia patients etc. The rising rates of cancer has created need for chemotherapy treatment which results in bone marrow depression and bleeding tendencies which require infusion of natural coagulant factors derived from blood. The excellent reimbursement for these class of drugs is also driving the market.
Test the market data and market information presented through more than 60 market data tables and figures spread over 84 numbers of pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “The Middle East and Africa Blood Coagulants Market Research Report – Forecast to 2022”.
Get a copy of sample report at https://www.marketresearchfuture.com/sample_request/2743 .
Key Players for Middle East and Africa Blood Coagulants Market:
Some of the key players in this market are: Shire Plc., Novo Nordisk, Bayer AG, Pfizer Inc., Octapharma, Biogen Inc., CSL Behring and others.
The market restraints are special requirements for storage and processing of coagulants, risks of adverse reactions which may be life threatening and concern of infections with coagulants derived from whole blood. Strict regulatory requirements regarding the manufacturer and use of these class of drugs is also hampering the market. The latest market trends include increasing use of advanced technology such as freeze dried coagulant products, use of recombination technology etc. The market is oligopolistic with a few players dominating the scene. The entry barriers are high for new firms and the switching costs for patients is high as there is considerable difference between same product manufactured by different players. The blood coagulant market favors companies with strong biotechnological skills and research and development pipeline. It is also a sector requiring specialized infrastructure and skills thereby providing ample opportunities for contract manufacturing.
Middle East and Africa Blood Coagulants market:
The Middle East and Africa blood coagulants market has been evaluated as a growing market and it is expected that the market will touch moderate growth figures in future. The Middle East and Africa blood coagulating drugs market is expected to grow with CAGR of ~9.5% during the forecast period. The growth will be primarily led by the need of unmet medical needs and rising incomes of the population.
The major participants of this market are: Shire Plc., Novo Nordisk, Bayer AG, Pfizer Inc., Octapharma, Biogen Inc., CSL Behring and others.
Request for Discount @ https://www.marketresearchfuture.com/check-discount/2743 .
Study Objectives Middle East and Africa Blood Coagulants Market: To provide detail analysis of the market structure along with forecast for the next 6 years of the various segments and sub-segments of the Middle East and Africa blood coagulants market, To provide insights about factors affecting the market growth, To analyze the market based on various factors- price analysis, supply chain analysis, Porters Five Force analysis etc. To provide historical and forecast revenue of the market segments and sub-segments for Middle East and Africa blood coagulants market, To provide country level analysis of the market with respect to the current market size and future prospective, To provide country level analysis of the market for segments by drug class and by clinical indication and other sub segments. To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market, To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments globally.
Depending on geographic region, blood coagulants market is segmented into following countries: UAE, Egypt, Saudi Arabia, Kuwait, Qatar and Oman. UAE is the largest market followed by Egypt. Another market with a high growth rate is Saudi Arabia due to rise in health expenditure of government and the rise in disposable income. Algeria and South Africa lead the other African nations due to better performance in health sector. However the future market will be led by the poor developed parts of Africa due to large unmet needs.
Middle East and Africa blood coagulants market has been segmented on the basis of drug class which comprises of coagulation factor which is further sub-segmented into plasma derived and recombinant coagulation factor; vitamin K analogues, fibrinogen analogues and others. On the basis of clinical indications; market is segmented into accidents, surgery, hemophilia and others.
Complete Report Available at https://www.marketresearchfuture.com/reports/blood-coagulants-market-2743 .
List Of Tables
TABLE 1 MIDDLE EAST AND AFRICA BLOOD COAGULANTS MARKET, 2013-2022 (USD MILLION)
TABLE 2 MIDDLE EAST AND AFRICA BLOOD COAGULANTS MARKET, BY DRUG CLASS, 2013-2022 (USD MILLION)
TABLE 3 MIDDLE EAST AND AFRICA BLOOD COAGULANTS MARKET, BY CLINICAL INDICATIONS, 2013-2022 (USD MILLION)
TABLE 4 MIDDLE EAST AND AFRICA BLOOD COAGULANTS MARKET, BY REGION, 2013-2022 (USD MILLION)
List Of Figures
FIGURE 1 RESEARCH PROCESS
FIGURE 2 PORTERS FIVE FORCES MODEL
FIGURE 3 MIDDLE EAST AND AFRICA BLOOD COAGULANTS MARKET, BY DRUG CLASS
FIGURE 4 MIDDLE EAST AND AFRICA BLOOD COAGULANTS MARKET, BY CLINICAL INDICATIONS
FIGURE 5 MIDDLE EAST AND AFRICA BLOOD COAGULANTS MARKET, BY REGION
FIGURE 6 MIDDLE EAST AND AFRICA BLOOD COAGULANTS MARKET: COMPANY SHARE ANALYSIS, 2015 (%)
Company Name: Market Research Future
Contact Person: Akash Anand
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –